Bailey Eye Care - Medicare Optometrist in Barboursville, WV

Bailey Eye Care is a medicare enrolled "Optometrist" provider in Barboursville, West Virginia. Their current practice location is 6010 Us Route 60 E, Barboursville, West Virginia. You can reach out to their office (for appointments etc.) via phone at (304) 733-0808.

Bailey Eye Care is licensed to practice in West Virginia (license number 717-OD) and it also participates in the medicare program. Bailey Eye Care is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1831236827.

Contact Information

Bailey Eye Care
6010 Us Route 60 E,
Barboursville, WV 25504-1029
(304) 733-0808
(304) 733-4234



Healthcare Provider's Profile

Full NameBailey Eye Care
TypeFacility
SpecialityOptometrist
Location6010 Us Route 60 E, Barboursville, West Virginia
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1831236827
  • Provider Enumeration Date: 01/31/2007
  • Last Update Date: 01/22/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 3274540646
  • Enrollment ID: O20060309000229

Medical Identifiers

Medical identifiers for Bailey Eye Care such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1831236827NPI-NPPES
0150705001MedicaidWV

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 717-OD (West Virginia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Bailey Eye Care acts as a billing entity for following providers:
Provider NameKimberly F Epling
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1073616355
PECOS PAC ID: 1456256098
Enrollment ID: I20031205000276

News Archive

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

Study illustrates contribution of obesity to decreased mobility in high functioning older women with osteoarthritis

Osteoarthritis, common among older adults, is strongly linked to late-life disability, but the process by which this happens has not been well studied.

Read more Medical News

› Verified 8 days ago

Provider NameMelissa L Leoni
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1184675746
PECOS PAC ID: 6406872415
Enrollment ID: I20051019000621

News Archive

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

Study illustrates contribution of obesity to decreased mobility in high functioning older women with osteoarthritis

Osteoarthritis, common among older adults, is strongly linked to late-life disability, but the process by which this happens has not been well studied.

Read more Medical News

› Verified 8 days ago

Provider NameSteven Glenn Bailey
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1699737759
PECOS PAC ID: 5294744603
Enrollment ID: I20111207000130

News Archive

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

Study illustrates contribution of obesity to decreased mobility in high functioning older women with osteoarthritis

Osteoarthritis, common among older adults, is strongly linked to late-life disability, but the process by which this happens has not been well studied.

Read more Medical News

› Verified 8 days ago

Provider NameKayla J Campbell
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1306253166
PECOS PAC ID: 4880815059
Enrollment ID: I20141103000284

News Archive

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

Study illustrates contribution of obesity to decreased mobility in high functioning older women with osteoarthritis

Osteoarthritis, common among older adults, is strongly linked to late-life disability, but the process by which this happens has not been well studied.

Read more Medical News

› Verified 8 days ago

Provider NameBryce T Peek
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1881268563
PECOS PAC ID: 9537565072
Enrollment ID: I20210908001557

News Archive

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

Study illustrates contribution of obesity to decreased mobility in high functioning older women with osteoarthritis

Osteoarthritis, common among older adults, is strongly linked to late-life disability, but the process by which this happens has not been well studied.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bailey Eye Care is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Bailey Eye Care
6010 Us Route 60 E,
Barboursville, WV 25504-1029

Ph: (304) 733-0808
Bailey Eye Care
6010 Us Route 60 E,
Barboursville, WV 25504-1029

Ph: (304) 733-0808

News Archive

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

Study illustrates contribution of obesity to decreased mobility in high functioning older women with osteoarthritis

Osteoarthritis, common among older adults, is strongly linked to late-life disability, but the process by which this happens has not been well studied.

Read more News

› Verified 8 days ago


Optometrist in Barboursville, WV

Ms. Melissa Louise Leoni, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 6010 Us Route 60 E, Barboursville, WV 25504
Phone: 304-733-0809    Fax: 304-733-4234
Kayla Campbell, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 6010 Us Route 60 E, Barboursville, WV 25504
Phone: 304-733-0809    Fax: 304-733-4234
Winfield Eye Care Center, Inc.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 3540 Route 60 East, Barboursville, WV 25504
Phone: 304-733-5355    Fax: 304-733-9743
Dr. Steven Glenn Bailey, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 6010 Route 60 East, Barboursville, WV 25504
Phone: 304-733-0809    Fax: 304-733-4234
Optometric Associates, Inc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 404 Huntington Mall Unit 580, Barboursville, WV 25504
Phone: 304-736-4942    
Bryce Tanner Peek, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 6010 Us Route 60 E, Barboursville, WV 25504
Phone: 304-733-0809    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.